China’s Ascletis Shares Surge on Oral Weight-Loss Drug Data
Ascletis Pharma Inc. shares surged Tuesday, posting their biggest rally since April, after mid-stage results for its oral weight-loss drug suggested a potential best-in-class profile.
By Amber Tong · Bloomberg Markets
Ascletis Pharma Inc. shares surged Tuesday, posting their biggest rally since April, after mid-stage results for its oral weight-loss drug suggested a potential best-in-class profile.